Delivery Order SPE2DB22D2206-SPE2DB26FDU83
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of 36,000 units of Creon DR 100 strength capsules, valued at $9,284.69. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by October 28, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Creon DR 24,000 unit capsules in quantities of 100s, with a ceiling value of $1,718.56. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 36,000 unit capsules of Creon DR 100s with a ceiling value of $58,274.04. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 units at a ceiling value of $6,003.41. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $9,788.44. This is a firm fixed price delivery order with an ultimate completion date of October 30, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made without a set-aside designation, indicating that AmerisourceBergen competed for this order on an open basis. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 24,000 units of Creon DR capsules in 100-unit packaging, with a contract ceiling value of $6,525.39 and completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for 36,000 units of Creon DR 100s capsules with a ceiling value of $5,071.22. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $46,171.42. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $5,151.86 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Creon DR 12,000 unit capsules in packages of 100 units. This is a firm fixed price delivery order with no set-aside designation, reflecting an open competitive award to this major pharmaceutical distributor. The order is scheduled for completion by September 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDU83Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,577.88 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Creon DR 36,000 unit capsules (100-count packages). This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement in the open market. Performance will be completed by October 30, 2025, and the work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 10/29/25 |